METHODS: Patients (n = 57) and providers (n = 100) were recruited from a large healthcare system over five months. Participants completed a survey assessing attitudes towards DMHAs, and perceived facilitators and barriers to adoption and utilization of DMHAs in mental healthcare.
RESULTS: DMHA credibility was a key facilitator for provider adoption, while usability and accessibility were identified as key facilitators for patient utilization. Provider barriers included patient cost/provider reimbursement, limited knowledge, perceived limits to credibility, patient outcome enhancement, and personalization of DMHAs for patient needs. Patients identified privacy concerns as the top barrier for using DMHAs.
CONCLUSIONS: The self-report survey nature of this study, modest sample size, and majority of sample identifying as White and upper middle class make results subject to biases and limitations. Given the potential of DMHAs to address disparities in access to mental healthcare, more research is needed including populations who are at greatest risk.
CONCLUSIONS: Findings provide new insights to inform the development of intervention strategies to improve the integration of DMHAs within healthcare systems. Additional research examining key stakeholders at different levels of care is critical to address barriers, optimize facilitators, and develop roadmaps for best-practice use in healthcare systems.
方法:患者(n=57)和提供者(n=100)从大型医疗保健系统中招募超过5个月。参与者完成了一项调查,评估他们对DMHA的态度,以及在精神保健中采用和利用DMHAs的感知促进者和障碍。
结果:DMHA可信度是提供者采用的关键促进因素,而可用性和可及性被确定为患者利用的关键促进因素。提供者障碍包括患者费用/提供者报销,知识有限,感知到的可信度限制,患者预后增强,和个性化的DMHAs患者的需求。患者认为隐私问题是使用DMHA的最大障碍。
结论:本研究的自我报告调查性质,样本量适中,大多数样本被认定为白人和中上层阶级,使得结果受到偏见和限制。鉴于DMHA在解决获得精神医疗保健方面的差距方面的潜力,需要更多的研究,包括风险最大的人群。
结论:研究结果为制定干预策略提供了新的见解,以改善DMHA在医疗保健系统中的整合。对不同护理水平的关键利益相关者进行额外的研究对于解决障碍至关重要,优化促进者,并为医疗保健系统中的最佳实践使用制定路线图。